FDA Inspection 1016474 — Andrew R. Gould, M.D.
The FDA completed an inspection of Andrew R. Gould, M.D. on June 19, 2017 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Louisville, KY (United States)
Additional Details
Clinical Investigator (CI)